Grimes & Company, Inc. Coh Bar, Inc. Transaction History

Grimes & Company, Inc.

  • $3.66 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
SELL
$0.17 - $0.34 $3,230 - $6,460
-19,000 Closed
0 $0
Q1 2022

May 06, 2022
BUY
$0.25 - $0.43 $4,750 - $8,170
19,000 New
19,000 $6,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0
View Full List

About CohBar, Inc.

CWBR Quotes by TradingView
  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.57M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email